wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46434054-30F1AD29-39B3-452D-977E-9080D3901286
Q46434054-30F1AD29-39B3-452D-977E-9080D3901286
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46434054-30F1AD29-39B3-452D-977E-9080D3901286
Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab.
P2860
Q46434054-30F1AD29-39B3-452D-977E-9080D3901286
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46434054-30F1AD29-39B3-452D-977E-9080D3901286
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ca7901fc01c70bf186093fb8bdf7880126bb69a
P2860
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment.